Imitrex and Anzemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imitrex (sumatriptan succinate) and Anzemet (dolasetron mesylate). Common drug interactions include injury among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Imitrex and Anzemet. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,149 Imitrex users. Check the latest studies of Imitrex.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

On Jul, 12, 2026

49 people who take Imitrex and Anzemet together, and have interactions are studied.

What are the common drug interactions of Imitrex and Anzemet, by gender? *:

female:

Injury
Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone)
Rib fracture
Arthralgia (joint pain)
Hepatic cyst
Oral pain
Nausea (feeling of having an urge to vomit)
Osteonecrosis of jaw (death of bone of jaw)
Abdominal pain
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)

male:

Pneumonia
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Blepharitis (chronic inflammation of the eyelid)

What are the common drug interactions of Imitrex and Anzemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Febrile neutropenia (fever with reduced white blood cells)
Oxygen saturation decreased
Septic shock (shock due to blood infection)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vomiting

50-59:

Injury
Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone)
Rib fracture
Arthralgia (joint pain)
Hepatic cyst
Oral pain
Osteonecrosis of jaw (death of bone of jaw)
Abdominal pain
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Blood alkaline phosphatase increased

60+:

Pneumonia
Acute myocardial infarction (acute heart attack)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Blepharitis (chronic inflammation of the eyelid)
Bone pain

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 24 people, 48.98%
Neoplasm Malignant (cancer tumour): 24 people, 48.98%
Hot Flush (sudden feelings of heat): 24 people, 48.98%
Discomfort: 24 people, 48.98%
Breast Cancer Metastatic: 24 people, 48.98%
Breast Cancer: 24 people, 48.98%
Granulocyte Count Decreased: 23 people, 46.94%
Depression: 21 people, 42.86%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 21 people, 42.86%
Sleep Disorder: 13 people, 26.53%

* Approximation only. Some reports may have incomplete information.

Do you take Imitrex and Anzemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously